🇺🇸 FDA
Pipeline program

Hema-NeoTIL01

Hema-NeoTIL01-SU01

Phase 1 mab active

Quick answer

Hema-NeoTIL01 for Leukemia, Myeloid, Acute is a Phase 1 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Leukemia, Myeloid, Acute
Phase
Phase 1
Modality
mab
Status
active

Clinical trials